OA12893A - Broadspectrum 2-Amino-Benzothiazole Sulfonamide HIV Protease Inhibitors. - Google Patents

Broadspectrum 2-Amino-Benzothiazole Sulfonamide HIV Protease Inhibitors. Download PDF

Info

Publication number
OA12893A
OA12893A OA1200500026A OA1200500026A OA12893A OA 12893 A OA12893 A OA 12893A OA 1200500026 A OA1200500026 A OA 1200500026A OA 1200500026 A OA1200500026 A OA 1200500026A OA 12893 A OA12893 A OA 12893A
Authority
OA
OAPI
Prior art keywords
amino
benzyl
sulfonyl
hydroxy
isobutyl
Prior art date
Application number
OA1200500026A
Other languages
English (en)
French (fr)
Inventor
Dominique Louis Nestor Ghislain Surleraux
Piet Tom Bert Paul Wigerinck
Daniel P Getman
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of OA12893A publication Critical patent/OA12893A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
OA1200500026A 2002-08-02 2003-08-04 Broadspectrum 2-Amino-Benzothiazole Sulfonamide HIV Protease Inhibitors. OA12893A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02078231 2002-08-02
US42786202P 2002-11-20 2002-11-20

Publications (1)

Publication Number Publication Date
OA12893A true OA12893A (en) 2006-10-13

Family

ID=38068099

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200500026A OA12893A (en) 2002-08-02 2003-08-04 Broadspectrum 2-Amino-Benzothiazole Sulfonamide HIV Protease Inhibitors.

Country Status (5)

Country Link
JP (1) JP4879484B2 (zh)
KR (1) KR101327772B1 (zh)
CN (1) CN101445493A (zh)
OA (1) OA12893A (zh)
ZA (1) ZA200500926B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA103013C2 (uk) * 2007-12-06 2013-09-10 Тиботек Фармасьютикелз Амідні сполуки як активатори противірусних препаратів
WO2012145728A1 (en) * 2011-04-21 2012-10-26 Gilead Sciences, Inc. Benzothiazole compounds and their pharmaceutical use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0715618B1 (en) * 1993-08-24 1998-12-16 G.D. Searle & Co. Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
US5756533A (en) * 1995-03-10 1998-05-26 G.D. Searle & Co. Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
WO1997018205A1 (en) * 1995-11-15 1997-05-22 G.D. Searle & Co. Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
WO1999067254A2 (en) * 1998-06-23 1999-12-29 The United States Of America Represented By The Secretary, Department Of Health And Human Services Multi-drug resistant retroviral protease inhibitors and use thereof
AP1459A (en) * 1999-10-06 2005-08-22 Tibotec Pharm Ltd Hexahydrofuro [2,3-b] furan-3- YL-N-{3-[(1,3- benzodioxol-5- ylsufonyl) (isobutyl) amino]-1-benzyl-2-hydroxypropyl} carbamate as retroviral protease inhibitor.
EE05385B1 (et) * 2001-02-14 2011-02-15 Tibotec�Pharmaceuticals�Ltd. LaiaspektrilisedÁ2-(asendatudÁamino)bensotiasoolsulfoonamiididÁkuiÁHIVÁproteaasiÁinhibiitorid,ÁnendeÁvalmistamismeetodÁjaÁkasutamineÁningÁfarmatseutilineÁkompositsioon

Also Published As

Publication number Publication date
KR101327772B1 (ko) 2013-11-11
CN101445493A (zh) 2009-06-03
JP2006503815A (ja) 2006-02-02
KR20100137584A (ko) 2010-12-30
JP4879484B2 (ja) 2012-02-22
ZA200500926B (en) 2006-03-29

Similar Documents

Publication Publication Date Title
US20090203742A1 (en) Broadspectrum 2-amino-benzothiazole sulfonamide hiv protease inhibitors
AU2002302363B2 (en) Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors
IL166462A (en) Broadspectrum substituted oxindole sulfonamide hiv protease inhibitors
OA13134A (en) Broadspectrum 2-amino-benzoxazole sulfamide HIV protease inhibitors.
US8143421B2 (en) Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors
CA2442870C (en) Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors
CA2485903C (en) Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors
KR100942743B1 (ko) 광범위 스펙트럼 헤테로사이클릭 치환된 페닐 포함설폰아미드 ｈｉｖ 프로테아제 저해제
OA12893A (en) Broadspectrum 2-Amino-Benzothiazole Sulfonamide HIV Protease Inhibitors.
IL163960A (en) Benzimidazoles Sulphonamides are broad-spectrum as vih protease inhibitors and as an overall preparation